Status:
COMPLETED
Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian Cancer
Lead Sponsor:
City of Hope Medical Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
RATIONALE: Palliative care may help improve the quality of life of patients with ovarian cancer who are undergoing intraperitoneal chemotherapy. PURPOSE: This clinical trial is studying palliative ca...
Detailed Description
OBJECTIVES: * Describe symptoms/concerns before, during, and after intraperitoneal (IP) chemotherapy and the impact of these symptoms/concerns on the quality of life (QOL) of patients with ovarian ca...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Diagnosis of ovarian cancer
- Under the care of the Medical Oncology Department at the City of Hope National Medical Center
- Undergoing intraperitoneal chemotherapy
- PATIENT CHARACTERISTICS:
- Life expectancy \> 6 months
- Speaks English or Spanish
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Exclusion
Key Trial Info
Start Date :
August 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT00804258
Start Date
August 1 2007
End Date
January 1 2012
Last Update
November 6 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
City of Hope Comprehensive Cancer Center
Duarte, California, United States, 91010-3000